Brief: Xintela Publishes Positive Preclinical Results From XSTEM Treatment Of ARDS
09/06/2023 14:16
June 9 (Reuters) - Xintela AB XINT.ST :
* XINTELA PUBLISHES POSITIVE PRECLINICAL RESULTS FROM XSTEM
TREATMENT OF ARDS
* RESULTS SHOW THAT XSTEM HAS THERAPEUTIC EFFECT, PROVIDES
MORE
STABLE BLOOD CIRCULATION, REDUCED LUNG TISSUE DAMAGE AND REDUCED
BLOOD CLOTTING COMPARED TO PLACEBO
Source text for Eikon: ID:nMFN9sF77
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects